These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 8019993)
1. 5-Fluorouracil attenuates an oncostatic effect of melatonin on estrogen-sensitive human breast cancer cells (MCF7). Furuya Y; Yamamoto K; Kohno N; Ku Y; Saitoh Y Cancer Lett; 1994 Jun; 81(1):95-8. PubMed ID: 8019993 [TBL] [Abstract][Full Text] [Related]
2. The growth inhibitory action of melatonin on human breast cancer cells is linked to the estrogen response system. Hill SM; Spriggs LL; Simon MA; Muraoka H; Blask DE Cancer Lett; 1992 Jul; 64(3):249-56. PubMed ID: 1638517 [TBL] [Abstract][Full Text] [Related]
3. Title aggregation patterns of argyrophilic nucleolar organizer regions induced by 5-fluorouracil in the nuclei of MCF-7 human breast cancer cells. Nishihara T; Furuya Y; Yamamoto K; Saitoh Y Cancer Lett; 1996 Feb; 100(1-2):95-8. PubMed ID: 8620459 [TBL] [Abstract][Full Text] [Related]
4. [Effect of medroxyprogesterone acetate on the anticellular activity of 5-fluorouracil against human breast and stomach cancer cells]. Ishida H; Okabe M; Gomi K; Horiuchi R Gan To Kagaku Ryoho; 1993 Apr; 20(5):625-30. PubMed ID: 8470920 [TBL] [Abstract][Full Text] [Related]
5. Physiological melatonin inhibition of human breast cancer cell growth in vitro: evidence for a glutathione-mediated pathway. Blask DE; Wilson ST; Zalatan F Cancer Res; 1997 May; 57(10):1909-14. PubMed ID: 9157984 [TBL] [Abstract][Full Text] [Related]
6. Sequence-dependent administration of 5-fluorouracil maintains methotrexate antineoplastic activity in human estrogen-negative breast cancer and protects against methotrexate cytotoxicity in human bone marrow. Das JR; Fryar-Tita EB; Zhou Y; Green S; Southerland WM; Bowen D Anticancer Res; 2007; 27(6B):3791-9. PubMed ID: 18225534 [TBL] [Abstract][Full Text] [Related]
7. Effects of the pineal hormone melatonin on the proliferation and morphological characteristics of human breast cancer cells (MCF-7) in culture. Hill SM; Blask DE Cancer Res; 1988 Nov; 48(21):6121-6. PubMed ID: 3167858 [TBL] [Abstract][Full Text] [Related]
8. Effects of melatonin on proliferation of cancer cell lines. Papazisis KT; Kouretas D; Geromichalos GD; Sivridis E; Tsekreli OK; Dimitriadis KA; Kortsaris AH J Pineal Res; 1998 Dec; 25(4):211-8. PubMed ID: 9885990 [TBL] [Abstract][Full Text] [Related]
9. Melatonin inhibits both ER alpha activation and breast cancer cell proliferation induced by a metalloestrogen, cadmium. Martínez-Campa C; Alonso-González C; Mediavilla MD; Cos S; González A; Ramos S; Sánchez-Barceló EJ J Pineal Res; 2006 May; 40(4):291-6. PubMed ID: 16635015 [TBL] [Abstract][Full Text] [Related]
10. Selenium Nanoparticles Induce the Chemo-Sensitivity of Fluorouracil Nanoparticles in Breast and Colon Cancer Cells. Abd-Rabou AA; Shalby AB; Ahmed HH Biol Trace Elem Res; 2019 Jan; 187(1):80-91. PubMed ID: 29748931 [TBL] [Abstract][Full Text] [Related]
11. Melatonin and mammary cancer: a short review. Sánchez-Barceló EJ; Cos S; Fernández R; Mediavilla MD Endocr Relat Cancer; 2003 Jun; 10(2):153-9. PubMed ID: 12790777 [TBL] [Abstract][Full Text] [Related]
12. Wide range for optimal concentration of folinic acid in fluorouracil modulation--experimental data on human tumour cell lines. Beck A; Etienne MC; Chéradame S; Fischel JL; Formento P; Guillot T; Milano G Eur J Cancer; 1994; 30A(10):1522-6. PubMed ID: 7833112 [TBL] [Abstract][Full Text] [Related]
13. Melatonin as an Oncostatic Molecule Based on Its Anti-Aromatase Role in Breast Cancer. Jin Y; Choi YJ; Heo K; Park SJ Int J Mol Sci; 2021 Jan; 22(1):. PubMed ID: 33406787 [TBL] [Abstract][Full Text] [Related]
14. Melatonin augments the sensitivity of MCF-7 human breast cancer cells to tamoxifen in vitro. Wilson ST; Blask DE; Lemus-Wilson AM J Clin Endocrinol Metab; 1992 Aug; 75(2):669-70. PubMed ID: 1639964 [TBL] [Abstract][Full Text] [Related]
15. Estrogen-signaling pathway: a link between breast cancer and melatonin oncostatic actions. Cos S; González A; Martínez-Campa C; Mediavilla MD; Alonso-González C; Sánchez-Barceló EJ Cancer Detect Prev; 2006; 30(2):118-28. PubMed ID: 16647824 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of Fatty Acid Synthase (FASN) synergistically enhances the efficacy of 5-fluorouracil in breast carcinoma cells. Vazquez-Martin A; Ropero S; Brunet J; Colomer R; Menendez JA Oncol Rep; 2007 Oct; 18(4):973-80. PubMed ID: 17786362 [TBL] [Abstract][Full Text] [Related]
17. ELF magnetic fields, breast cancer, and melatonin: 60 Hz fields block melatonin's oncostatic action on ER+ breast cancer cell proliferation. Liburdy RP; Sloma TR; Sokolic R; Yaswen P J Pineal Res; 1993 Mar; 14(2):89-97. PubMed ID: 8320637 [TBL] [Abstract][Full Text] [Related]
18. Melatonin attenuates hydrogen peroxide toxicity in MCF7 cells only at pharmacological concentrations. Baldwin WS; Barrett JC Biochem Biophys Res Commun; 1998 Sep; 250(3):602-5. PubMed ID: 9784392 [TBL] [Abstract][Full Text] [Related]
19. Preclinical rationale for combined use of endocrine therapy and 5-fluorouracil but neither doxorubicin nor paclitaxel in the treatment of endocrine-responsive breast cancer. Kurebayashi J; Nukatsuka M; Sonoo H; Uchida J; Kiniwa M Cancer Chemother Pharmacol; 2010 Jan; 65(2):219-25. PubMed ID: 19455332 [TBL] [Abstract][Full Text] [Related]
20. Nocturnal 5-fluorouracil infusion to patients with breast cancer prior to surgery: appearance of 5-fluorouracil-induced AgNORs aggregation (FAA). Furuya Y; Yamamoto K; Kohno N; Yamamoto M; Saitoh Y Cancer Lett; 1997 Jun; 116(1):79-84. PubMed ID: 9177461 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]